Dr. Eva Medvedova, MD
- Medicare services, 2024
- 1,170
- Medicare patients, 2024
- 236
- Part D claims, 2024
- 1,320
- Publications
- 21
- Clinical trials
- 5
- Practice address
- 3181 SW Sam Jackson Park Road, Portland, OR 97239
- Practice phone
- Call (503) 494-9000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Medvedova's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Eva Medvedova is a hematology (internal medicine) physician in Portland, Oregon
Dr. Medvedova practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.
Dr. Medvedova's NPI, 1831242718, was assigned on January 22, 2007. Dr. Medvedova holds Oregon license MD163041.
- NPI
- 1831242718NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305034950
- NPI enumeration date
- January 22, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (503) 494-9000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Eva Medvedova practices at OHSU Hospital in Portland, Oregon
Dr. Medvedova's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.
- OHSU Hospital3181 SW Sam Jackson Park Road, Portland, OR 97239 · Multnomah CountyPhone(503) 494-9000
Source: Dmand AI Affiliation Data
Dr. Eva Medvedova is affiliated with 6 sites of care and 1 medical group
Dr. Medvedova's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Medvedova is also affiliated with Adventist Health Portland. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Medvedova to 3 more hospitals and 1 clinical lab, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Eva Medvedova's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medvedova practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| OHSU Hospital | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across State of Oregon and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Eva Medvedova is one of 24 hematology (internal medicine) physicians in Oregon
Internal medicine is Dr. Medvedova's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Medvedova's licenses on file in 2 states: Oregon and Massachusetts.
Specialties and state licenses
- Hematology (internal medicine), OregonPrimary
- Internal medicine, Massachusetts
Hematology (internal medicine) physicians near Dr. Medvedova
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Eva Medvedova billed Medicare for 1,170 services in 2024
CMS data shows 1,170 Medicare services from Dr. Medvedova across 8 procedure codes in 2024, for 236 Medicare patients. Medicare paid $77,781 for them.
Dr. Medvedova's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7392024: 7735%
- Other services
- 2023: 02024: 397
Where Dr. Medvedova's Medicare services took place, 2024
- In an office16814%
- In a facility1,00286%
Dr. Medvedova compared with the Oregon median for hematology (internal medicine) physicians, 2024
- Dr. Medvedova
- Oregon median
- Medicare services
- 1,170vs 4752.5 times
- Medicare patients
- 236vs 13180% above
- Part D claims
- 1,122vs 4442.5 times
Medians across 22 hematology (internal medicine) physicians in Oregon with Dmand AI profiles that report each measure.
Dr. Medvedova's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Medvedova?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Medvedova and other hematology (internal medicine) physicians in Oregon.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Eva Medvedova treated 236 Medicare patients in 2024, average age 71
CMS counts 236 Medicare patients who saw Dr. Medvedova in 2024. The largest group is 65 to 74, with 130 patients. 65% of them have high blood pressure, and 59% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Medvedova's median patient age at 72, with 50% women.
Dr. Medvedova's Medicare patients by age, 2024
Dr. Medvedova's Medicare patients by sex, 2024
- Women11549%
- Men12151%
Chronic conditions among Dr. Medvedova's Medicare patients, 2024
- High blood pressure65%
- High cholesterol59%
- Arthritis36%
- Chronic kidney disease33%
- Heart failure30%
- Mood disorders26%
- Atrial fibrillation25%
- Depression24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Medvedova's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women50%
- Men50%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Eva Medvedova wrote 1,320 Medicare Part D claims in 2024
In 2024, Dr. Medvedova wrote 1,320 Medicare Part D claims for 133 patients. 79% of them were for generic drugs. CMS names the drug for 1,122 of them, across 28 drugs with 11 or more claims each, at $6,812,052 in total drug cost. In 2023, CMS named 944 claims across 28 drugs.
Dr. Medvedova's Part D claims by kind of drug, 2024
- Generic1,039 claims79%
- Brand-name281 claims21%
Dr. Medvedova's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Medvedova's Part D claims, 2024
- Opioids5%66 of 1,320 claims
- Antibiotics5%61 of 1,320 claims
- Antipsychotics, patients 65 and over2%24 of 1,320 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9442024: 1,12219%
Drugs named by CMS: 28 in 2024, 28 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Eva Medvedova scored 99 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Medvedova for performance year 2024, reported through an alternative payment model (APM). Dr. Medvedova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Medvedova as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Medvedova's MIPS scores, performance year 2024
- 99of 100Final score
- 84.3of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Eva Medvedova has 21 publications on record
Dmand AI links 21 papers to Dr. Medvedova, published from 2011 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Dexamethasone. Dr. Medvedova has published most often in Clin Lymphoma Myeloma Leuk. Dr. Medvedova's most frequent co-authors are Rebecca Wang Silbermann, MD, Susan Bal and Natalie S. Callander, MD.
Dr. Medvedova's papers by year, 2011 to 2025
Topics Dr. Medvedova writes about most
- Multiple Myeloma
- Antineoplastic Combined Chemotherapy Protocols
- Dexamethasone
- Bortezomib
- Lenalidomide
- Antibodies, Monoclonal
- Transplantation, Autologous
- Antineoplastic Agents
Dr. Medvedova's most frequent co-authors
- Rebecca Wang Silbermann, MD10 shared papers
- Susan Bal8 shared papers
- Natalie S. Callander, MD8 shared papers
Recent publications by Dr. Medvedova
N Engl J Med
See who Dr. Medvedova researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Medvedova works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Eva Medvedova has worked on 5 clinical trials
Dmand AI links Dr. Medvedova to 5 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Macroglossia. ECOG-ACRIN Cancer Research Group sponsors the most, 2.
Clinical trials with Dr. Medvedova by phase
- 1Phase 1: 1 trial
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Medvedova's trials
- Multiple Myeloma
- Blood Protein Disorders
- Macroglossia
- Smoldering Multiple Myeloma
- Hepatomegaly
Investigators on the most trials with Dr. Medvedova
- Manisha Bhutani, MD2 shared trials
- Erica Leigh Campagnaro, MD2 shared trials
- Caitlin L. Costello, MD2 shared trials
Recent clinical trials with Dr. Medvedova
A Phase II Study of Isatuximab (SAR650984) (NSC-795145) for Patients With Previously Treated AL Amyloidosis (opens in a new tab)
A Phase 1 Open-label, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients With Relapsed/Refractory Multiple Myeloma (opens in a new tab)
Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma - MASTER Trial (opens in a new tab)
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma (opens in a new tab)
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Eva Medvedova received $4,732 in industry payments from 2018 to 2025
CMS Open Payments shows 35 general payments to Dr. Medvedova from 2 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 74% of the total. Janssen Research & Development, LLC paid the most, $4,580.
General payments to Dr. Medvedova by program year, 2018 to 2025
General payments to Dr. Medvedova by kind, 2018 to 2025
- Travel and lodging$3,51274%
- Food and beverage$1,22126%
Companies that paid Dr. Medvedova the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Eva Medvedova's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Eva Medvedova
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Eva Medvedova's NPI number?
Dr. Eva Medvedova's NPI number is 1831242718. It was assigned on January 22, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Eva Medvedova?
Dr. Eva Medvedova is a hematology (internal medicine) physician in Portland, Oregon. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. Eva Medvedova practice?
Dr. Medvedova practices at 3181 SW Sam Jackson Park Road, Portland, OR 97239. Dr. Medvedova's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dmand AI also links Dr. Medvedova to 3 hospitals and 1 clinical lab.
What is Dr. Eva Medvedova's office phone number?
The practice phone on file for Dr. Medvedova is (503) 494-9000.
What is Dr. Eva Medvedova's medical license number?
Dr. Medvedova holds Oregon license MD163041, one of the licenses on file in 2 states.
Which states has Dr. Eva Medvedova been licensed in?
Dmand AI has state licenses on file for Dr. Medvedova in Oregon and Massachusetts.
Which hospitals is Dr. Eva Medvedova affiliated with?
Dr. Medvedova practices at OHSU Hospital in Portland, Oregon. Dr. Medvedova is also affiliated with Adventist Health Portland. Dmand AI links Dr. Medvedova to 3 more hospitals.
What medical group is Dr. Eva Medvedova part of?
Dr. Medvedova is linked to Oregon Health & Science University (OHSU).
Does Dr. Eva Medvedova accept Medicare?
Yes. CMS data shows Dr. Medvedova billed Medicare for 1,170 services in 2024, and Dr. Medvedova accepts Medicare assignment.
Does Dr. Eva Medvedova offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Medvedova as offering telehealth services.
Show 8 more questionsShow fewer questions
What is Dr. Eva Medvedova's MIPS score?
Dr. Medvedova's MIPS final score for performance year 2024 is 99 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Eva Medvedova see?
CMS counts 236 Medicare patients who saw Dr. Medvedova in 2024, with an average age of 71.
What services does Dr. Eva Medvedova bill to Medicare?
In 2024, Dr. Medvedova's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and hospital inpatient care (99233).
What drugs does Dr. Eva Medvedova prescribe most?
In 2024 Medicare Part D data, Dr. Medvedova's most prescribed drugs by claims were Acyclovir, Lenalidomide and Revlimid.
Has Dr. Eva Medvedova received payments from drug or device companies?
CMS Open Payments shows $4,732 in general payments to Dr. Medvedova from 2 companies from 2018 to 2025. The largest total came from Janssen Research & Development, LLC.
How long has Dr. Eva Medvedova been practicing?
Dr. Medvedova graduated from medical school in 2002, 24 years ago.
Does Dr. Eva Medvedova do research?
Dmand AI links 21 publications to Dr. Medvedova, published from 2011 to 2025. Dr. Medvedova has worked on 5 clinical trials.
Who does Dr. Eva Medvedova publish with?
Dr. Medvedova's most frequent co-authors are Rebecca Wang Silbermann, MD (10 shared papers), Susan Bal (8 shared papers) and Natalie S. Callander, MD (8 shared papers).
Selling to internal medicine practices?
See hematology (internal medicine) physicians in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card